The Wake Forest NCORP (NCI Community Oncology Research Program) Research Base is one of seven research bases funded by the NCI to develop and implement cancer prevention and control research for the NCORP community oncology research network. We partner with NCORP Community and Minority Underserved Community Sites across the county to test new approaches to cancer care delivery and the treatment, prevention and detection of cancer-related symptoms. Our goal is to conduct practice-changing cancer research that will improve patient outcomes.
Wake Forest NCORP provides the opportunity for community physicians to participate in NCI-supported treatment and cancer control and prevention trials. These trials test new approaches to cancer care delivery and the treatment, prevention and detection of cancer-related symptom management and outcomes.
Our goal is to conduct practice-changing cancer prevention and control research that will improve patient outcomes. Our studies are designed to be easy to implement and manage. Almost without exception, we will provide drugs for the study at no cost to the patient and limit any follow up to that which is relevant to the study.
Our accrual year runs from August 1 through the following July 31.
New Protocols
The Wake Forest NCORP Research Base has now implemented a password-protected web program for accessing all protocol documents and resources. For login information, visit the Member Area below.
Open Protocol Summaries
- WF2303CD Understanding and Enhancing Health-related Social Needs (HRSN) Screening Among Community Oncology Practices
- WF-2301CD Multi-site Community Oncology Planning for the CONNECT Intervention Targeting Lung Cancer Caregivers
- WF-2202 Optimizing Psychosocial Intervention for Breast Cancer-related Sexual Morbidity: The Sexual Health and Intimacy Education (SHINE) Trial
- WF-2201 Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy (HYPOGRYPHE)
- WF-1901 IMPACTS Internet-delivered Management of Pain Among Cancer Treatment Survivors
- WF-1805CD Implementation and Effectiveness Trial of HN-STAR
- WF-1806 Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
2024 Annual Meeting
Dates: October 21 - 23, 2024
Location: In-Person only at the Marriott Resort Myrtle Beach Grand Dunes in Myrtle Beach, SC